A pi­o­neer­ing im­muno-on­col­o­gy re­searcher heads back to Dana-Far­ber as Eli Lil­ly’s can­cer R&D group un­der­goes a wrench­ing change­up

Leena Gand­hi played a ma­jor role in ex­plor­ing the ther­a­peu­tic po­ten­tial of Keytru­da, Mer­ck’s megas­tar can­cer drug. Six years ago at Dana-Far­ber she mapped out …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER